Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

C20orf78 Inhibitors

SCP2D1 antisense RNA 1 is a part of the non-coding RNA (ncRNA) landscape of the human genome. Non-coding RNAs do not encode proteins but play crucial roles in regulating gene expression at the transcriptional and post-transcriptional levels. Antisense RNAs are a subgroup of ncRNAs that are transcribed from the strand of DNA opposite to the sense strand, from which a corresponding protein-coding messenger RNA (mRNA) is transcribed.The SCP2D1 antisense RNA 1 is specifically an antisense transcript to the gene encoding sterol carrier protein 2 domain containing 1 (SCP2D1). While the exact functions of SCP2D1 antisense RNA 1 are still being researched, antisense RNAs, in general, are known to regulate their counterpart sense mRNA in various ways. They can modulate gene expression through mechanisms such as RNA interference, genomic imprinting, RNA editing, and alteration of chromatin structure.

These antisense RNAs can bind to their complementary mRNA sequences to form double-stranded RNA structures. This pairing can interfere with the translation process, modulate mRNA stability and degradation, or affect the splicing of pre-mRNA. They can also recruit epigenetic modifiers to specific genomic regions, influencing gene expression indirectly.The study of SCP2D1 antisense RNA 1 and similar ncRNAs is an evolving field as they are implicated in a wide variety of biological processes and diseases. They can play roles in cellular differentiation, development, and metabolism. Furthermore, dysregulation of antisense RNAs has been associated with complex diseases, including cancer, neurodegenerative disorders, and heart diseases.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D binds to DNA and inhibits RNA synthesis, potentially affecting the expression of SCP2D1-AS1.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

α-Amanitin is a potent inhibitor of RNA polymerase II, which could reduce the transcription of SCP2D1-AS1.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Triptolide inhibits RNA Polymerase I, II, and III, possibly influencing SCP2D1-AS1 transcription.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

DRB is a transcription inhibitor that can impede RNA polymerase II elongation, potentially affecting SCP2D1-AS1 expression.

Flavopiridol Hydrochloride

131740-09-5sc-207687
10 mg
$317.00
(2)

Flavopiridol inhibits CDK9/cyclin T, a key component of the transcription elongation complex, potentially impacting SCP2D1-AS1 synthesis.

Rocaglamide

84573-16-0sc-203241
sc-203241A
sc-203241B
sc-203241C
sc-203241D
100 µg
1 mg
5 mg
10 mg
25 mg
$275.00
$474.00
$1639.00
$2497.00
$5344.00
4
(1)

Rocaglamide inhibits eukaryotic translation initiation, which might indirectly affect SCP2D1-AS1 mediated regulatory mechanisms.

Cordycepin

73-03-0sc-203902
10 mg
$101.00
5
(1)

Cordycepin (3'-deoxyadenosine) inhibits RNA polymerase, which might impact SCP2D1-AS1 expression.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Epigallocatechin gallate (EGCG) can modulate RNA expression and processing, potentially influencing SCP2D1-AS1.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

JQ1 inhibits BET bromodomain proteins, influencing chromatin remodeling and potentially affecting SCP2D1-AS1 expression.

Pladienolide B

445493-23-2sc-391691
sc-391691B
sc-391691A
sc-391691C
sc-391691D
sc-391691E
0.5 mg
10 mg
20 mg
50 mg
100 mg
5 mg
$299.00
$5699.00
$11099.00
$25500.00
$66300.00
$2875.00
63
(2)

Pladienolide B inhibits spliceosome, which could alter the splicing of pre-mRNA transcripts including SCP2D1-AS1.